臨床研究管理センター

Keyphrases

1. Pancreas 100%
2. Islet Isolation 96%
3. Islet 93%
4. Islet Transplantation 88%
5. Type 1 Diabetes Mellitus (T1DM) 78%
6. Islet Yield 51%
7. Type I Diabetes 51%
8. Chronic Pancreatitis 45%
9. Ductal Injection 44%
10. Japanese Patients 39%
11. Nicotinamide Adenine Dinucleotide (NAD+) 39%
12. Insulin 35%
13. Metabolism 32%
14. Fulminant Type 1 Diabetes 30%
15. Porcine Islets 30%
16. Human Pancreas 29%
17. Secretory System 28%
18. Islet Purification 28%
19. Pancreas Preservation 26%
20. Insulin-producing Cells 26%
21. Isolated Islets 26%
22. Type 2 Diabetic Patients 26%
23. Purification Process 26%
24. Insulin Administration 26%
25. Type 1 Diabetes Patients 26%
26. Human Fetal Liver 26%
27. Oncostatin M 26%
28. Fetal Liver Cells 26%
29. Vacuole 26%
30. Diffusion Magnetic Resonance Imaging (dMRI) 26%
31. Pancreatic Islet Isolation 26%
32. C-Jun N-terminal Kinase 26%
33. Glutamic Acid Decarboxylase 65 (GAD65) 24%
34. Clinical Managers 23%
35. Pancreatic Ductal 22%
36. Type 2 Diabetes Mellitus (T2DM) 22%
37. Maturity-onset Diabetes of the Young type 5 21%
38. Islet Graft Function 20%
39. Aging 19%
40. Pancreatitis 19%
41. Serum Levels 19%
42. Digestion 19%
43. Islet Autotransplantation 19%
44. Tacrolimus 18%
45. Body Mass Index 18%
46. Nicotinamide 18%
47. Antigen-specific CD4 T Cells 18%
48. Insulin Therapy 18%
49. Diabetic Patients 18%
50. Edmonton Protocol 17%
51. Insulin Independence 17%
52. Transplantation 17%
53. CD4+ T Cells 17%
54. Clinical Characteristics 17%
55. Diabetic Ketoacidosis 17%
56. Porcine Pancreas 17%
57. Clinical Trials 17%
58. Human Islets 16%
59. Clinical Course 16%
60. University Hospital 16%
61. Dryness 16%
62. HLA Class II 16%
63. Insulin Gene 16%
64. Genotype 16%
65. High Risk 16%
66. Metabolic Syndrome 16%
67. Iodixanol 15%
68. Peripheral Blood Mononuclear Cells 15%
69. Type 1 Regulatory T Cells 15%
70. Cell Destruction 15%
71. Questionnaire Survey 15%
72. Diabetes 15%
73. Anakinra 15%
74. Islet Equivalent 15%
75. Fasting Plasma Glucose 15%
76. Collagenase 15%
77. Pancreatic Endocrine Function 15%
78. Pancreatic Cells 15%
79. Brain-dead Donor 14%
80. Trypsin Activity 14%
81. Visceral Fat Area 14%
82. Guanine 14%
83. Dinucleotide 14%
84. Interleukin-6 14%
85. Human Pancreatic Progenitor Cells 13%
86. Clinical Outcomes 13%
87. Subcutaneous Tissue 13%
88. High Prevalence 13%
89. Proliferative Vitreoretinopathy 13%
90. Adult-onset Type 1 Diabetes 13%
91. Hepatocyte nuclear Factor 13%
92. Macular Edema 13%
93. Carotid Atherosclerosis 13%
94. Severe Hypertriglyceridemia 13%
95. Cytokine Expression Profile 13%
96. Adiponectin Gene 13%
97. Healthy Adults 13%
98. SPINK1 13%
99. Conjugation Capacity 13%
100. Visually Impaired 13%

Medicine and Dentistry

1. Islet Transplantation 61%
2. Insulin Dependent Diabetes Mellitus 58%
3. Diabetes 50%
4. Diabetes Mellitus 49%
5. Chronic Pancreatitis 45%
6. Maturity Onset Diabetes of the Young 43%
7. Autotransplantation 39%
8. Fulminant 32%
9. Transplantation 31%
10. Islet Cell Transplantation 29%
11. Copurification 26%
12. Programmed Cell Death 26%
13. Diffusion MRI 26%
14. Oncostatin M 26%
15. Dexamethasone 26%
16. Liver Cell 26%
17. Vacuolization 26%
18. Pancreatic Islet 26%
19. Pancreatectomy 23%
20. Edmonton Protocol 23%
21. Collagenase 19%
22. Phosphotransferase 19%
23. Tacrolimus 18%
24. T Cell 18%
25. Pancreatitis 18%
26. Endocrine Function 17%
27. Body Mass Index 16%
28. Diabetic Ketoacidosis 16%
29. Xerostomia 16%
30. Prevalence 16%
31. Trypsin Inhibitor 15%
32. Autoimmunity 15%
33. Peripheral Blood Mononuclear Cell 15%
34. Hemoglobin A1c 15%
35. Immunosuppressive Treatment 15%
36. Anakinra 15%
37. Antigen Specificity 15%
38. Infusion 14%
39. Insulin Release 14%
40. Mouth 14%
41. Iodixanol 14%
42. Anti-Inflammatory Drug 14%
43. Disease 14%
44. C-Peptide 14%
45. Interleukin 6 14%
46. Progenitor Cell 13%
47. Graft Dysfunction 13%
48. Disease Course 13%
49. Epithelial Cell 13%
50. Glucagon-Like Peptide-1 Agonist 13%
51. Insulin Treatment 13%
52. Electrocardiography 13%
53. Tumor Necrosis Factor 13%
54. Nephropathy 13%
55. Thymocyte Antibody 13%
56. Proliferative Retinopathy 13%
57. Glycyrrhiza Uralensis Root 13%
58. Patient with Diabetes 13%
59. T-Helper Cell 13%
60. Clinical Research 13%
61. Hepatocyte Nuclear Factor 1beta 13%
62. Phosphotransferase Inhibitor 13%
63. Hypertriglyceridemia 13%
64. Minimal Effective Dose 13%
65. Amino Terminal Sequence 13%
66. Rapamycin 13%
67. Interleukin-1 13%
68. Metabolic Syndrome 13%
69. IgG4-Related Disease 13%
70. Autoimmune Pancreatitis 13%
71. Mucosal Dryness 13%
72. Etanercept 13%
73. Climacterium 13%
74. Glutamate Decarboxylase 65 13%
75. Macular Edema 13%
76. ADP Ribosyl Cyclase 13%
77. Triacylglycerol 13%
78. Clinical Study 13%
79. Diagnostic Imaging 13%
80. Radix Paeoniae 13%
81. Alpha 1 Antitrypsin Concentrate 13%
82. Serine Peptidase Inhibitor Kazal Type 13%
83. Muscle Cramp 13%
84. Lymphocytopenia 13%
85. Lumbar Spinal Stenosis 13%
86. Intravenous Glucose Tolerance Test 13%
87. Growth Factor 12%
88. Menopausal Syndrome 11%
89. Blood Glucose 10%
90. Fibrinogen 10%
91. Dry Nose 9%
92. Human Embryonic Stem Cell 8%
93. Stem Cell Line 8%
94. Homeobox 8%
95. Virus Vector 8%
96. Adverse Event 8%
97. Immunoreactivity 7%
98. Preproinsulin 7%
99. Complications of Diabetes Mellitus 7%
100. Drug Therapy 7%